Vol 9, No 2 (2020)

Table of Contents

Editor’s Page

Appeal of Editor-in-Chief PDF (Українська)
D.D. Ivanov 85

The Gallery

Professor A.I. Gozhenko PDF (Українська)
D.D. Ivanov 86

Original Articles

Priority of cystatin C among other renal biomarkers for pre-eclampsia diagnosing PDF (Українська)
V.G. Marichereda, M.Yu. Holubenko, L.I. Berlinska 87-91
Kidneys and autonomic dysfunction in children and adolescents (part I) PDF
L.I. Vakulenko 92-98
10-year personal experience of rituximab use in nephrological patients PDF (Українська)
D.D. Ivanov, O.O. Dyadyk, S.O. Rotova, M.D. Ivanovа 99-104


Comparative analysis of recommendations for the management of patients with ANCA-associated vasculitis and kidney damage PDF (Русский)
I.Yu. Golovach, Ye.D. Yehudina 105-116


Management of patients on dialysis and with kidney transplant during COVID-19 coronavirus infection PDF (Українська) PDF
Federico Alberici, Elisa Delbarba, Chiara Manenti, Laura Econimo, Francesca Valerio, Alessandra Pola, Camilla Maffei, Stefano Possenti, Paola Gaggia, Ezio Movilli, Sergio Bove, Fabio Malberti, Marco Farina, Martina Bracchi, Ester Maria Costantino, Nicola Bossini, Mario Gaggiotti, Francesco Scolari 117-120
2019 Update of the Joint European League Against Rheumatism and European Renal Association — European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis PDF PDF (Українська)
No authors 121-125

Clinical Observation

A case of the secondary AA amyloidosis in Bekhterev’s disease: a successful 3-year therapy with adalimumab PDF (Русский)
D.D. Ivanov, O.H. Fedorenko, O.O. Dyadik 126-132